GlassScriptPhysician profile
Melissa Dugal Hebert
NPI 1316164676
$2,544.40
in general payments reported to CMS, 2019-2025
21 companies · $365 in 2025
The $365 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $156 · 2021: $274 · 2022: $439 · 2023: $543 · 2024: $378 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,286.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $589.38 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Corium, LLC | $475.74 | 2022-2025 | Azstarys |
| Tris Pharma INC | $228.10 | 2019-2023 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $152.33 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Ironshore Pharmaceuticals INC. | $146.78 | 2019-2024 | Jornay Pm |
| Aytu Biopharma, INC. | $137.78 | 2022 | |
| Pfizer INC. | $122.43 | 2019-2025 | |
| Shire North American Group INC | $118.89 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $106.89 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $76.79 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $60.71 | 2020-2025 | |
| Phadia US INC. | $60.15 | 2021-2022 | |
| Adlon Therapeutics L.P. | $58.60 | 2020-2021 | |
| Neos Therapeutics, LP | $58.56 | 2019-2023 | Cotempla Xr-Odt |
| Sobi, INC | $44.41 | 2021-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $28.01 | 2023 | Aptima |
| Sanofi-Aventis U.S. LLC | $20.47 | 2025 | |
| Kaleo, INC. | $16.34 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.79 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $14.02 | 2019 | |
| Sarepta Therapeutics, INC. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Hebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.